Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Leucine-rich repeat kinase 2 (LRRK2) is a key factor in Parkinson's disease (PD) development.
• LRRK2 mutations increase its kinase activity, leading to cytotoxicity, suggesting kinase inhibitors as potential therapeutics.
• Understanding cellular deficits caused by pathogenic LRRK2 and its substrates is crucial for developing effective treatments.

Purpose of the Study:

• To review the connection between intracellular trafficking defects and LRRK2-mediated phosphorylation.
• To highlight newly identified LRRK2 kinase substrates involved in cellular processes.

Main Methods:

• Literature review of studies on LRRK2, Parkinson's disease, and intracellular trafficking.
• Analysis of recent findings on LRRK2 phosphorylation targets.
• Synthesis of information linking LRRK2 activity to cellular dysfunction.

Main Results:

• LRRK2 is consistently shown to impair intracellular vesicular trafficking.
• A subset of proteins critical for trafficking are phosphorylated by LRRK2.
• These substrates are intricately involved in the cellular deficits observed in PD.

Conclusions:

• Pathogenic LRRK2 disrupts cellular functions through the phosphorylation of specific trafficking-related substrates.
• Targeting LRRK2 kinase activity or its substrates may offer disease-modifying strategies for Parkinson's disease.
• Further research into LRRK2 substrates is essential for understanding PD pathogenesis and developing novel therapies.